Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
June 3, 2021 10:14 AM 2 min read

Unprofitable Palantir, DoorDash CEO Packages Biggest in 2020; Far Exceed S&P 500 CEO Average: WSJ

by Anusuya Lahiri Benzinga Editor
Follow
  • Data analysis provider Palantir Technologies Inc (NYSE:PLTR) CEO Alexander Karp received compensation valued at $1.1 billion for 2020, including $798 million in options and $296 million in restricted stock, the Wall Street Journal reports.
  • Meal delivery provider DoorDash Inc (NYSE:DASH) CEO Tony Xu received restricted shares initially valued at over $400 million.
  • The median pay for S&P 500 CEOs in 2020 was $13.4 million, and the highest compensation package was valued at $211 million.
  • Neither Palantir nor DoorDash is profitable or part of the S&P 500 index.
  • Both the companies describe the awards as tools to retain and motivate their CEOs to drive the companies’ valuations.
  • Xu owns a 5% stake in DoorDash but retains 71% of its voting power. Karp holds 5.1% of Palantir’s voting power and also has voting agreements with the co-founders.
  • Xu founded DoorDash with Stanford University classmates in 2013. The company capitalized on the pandemic-induced restaurant-delivery order boom. It reported a revenue of $2.9 billion and a loss of $461 million in 2020.
  • Karp assisted Palantir when it was started in 2003 with PayPal Holdings Inc (NASDAQ:PYPL) co-founder Peter Thiel’s financial support. Palantir reported revenue of $1.1 billion and a net loss of $1.2 billion in 2020.
  • DoorDash’s stock price needs to average at least $501 for six months before late Nov. 2027 for Xu to receive 100% of the award worth $5.2 billion.
  • Karp’s award of Palantir options and restricted stock is worth $3.9 billion today under standard valuation techniques.
  • Tesla Inc’s (NASDAQ:TSLA) Elon Musk received a stock option grant valued at $2.28 billion in 2018. The share price rose almost 10-times during the period. Earlier this year, Musk received full title to a tranche of options worth $32 billion.
  • Price action: PLTR shares traded lower by 1.90% at $23.99, and PLTR shares are lower by 2.17% at $23.92 on the last check Thursday.
  • Image Courtesy: Wikimedia Commons
Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
NewsTechMediaWall Street Journal
DASH Logo
DASHDoorDash Inc
$160.510.11%
Overview
PLTR Logo
PLTRPalantir Technologies Inc
$131.720.24%
PYPL Logo
PYPLPayPal Holdings Inc
$40.370.20%
TSLA Logo
TSLATesla Inc
$417.44-%
DASH Logo
DASHDoorDash Inc
$160.510.11%
Overview
PLTR Logo
PLTRPalantir Technologies Inc
$131.720.24%
PYPL Logo
PYPLPayPal Holdings Inc
$40.370.20%
TSLA Logo
TSLATesla Inc
$417.44-%
Comments
Loading...